Login

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
ASSETS
Cash and cash equivalents
Restricted cash
Real estate:
Land
Building and improvements
In-place lease intangible assets
Construction in progress
Total real estate
Less: accumulated depreciation and amortization
Total real estate, net
Investments in unconsolidated entity
Intangible assets, net
Assets held for sale, net
Assets related to discontinued operations, net
Above-market lease intangible assets, net
Deferred rent receivable
Deferred leasing costs, net
Goodwill
Right-of-use lease assets
Interest rate swap asset
Interest rate swap asset, at fair value
Interest Rate Swap
Total interest rate swap asset, at fair value
Real estate assets and other assets held for sale, net
Other assets
Total assets
LIABILITIES AND EQUITY
Restricted reserves
Debt, net
Interest rate swap liability, at fair value
Interest Rate Swap
Total interest rate swap liability, at fair value
Redemptions payable
Distributions payable
Due to related parties
Related Party
Total due to related parties
Intangible liabilities, net
Lease liability
Below-market lease intangible liabilities, net
Right-of-use lease liabilities
Accrued expenses and other liabilities
Related Party
Total accrued expenses and other liabilities
Liabilities held for sale
Liabilities related to discontinued operations
Total liabilities
Perpetual convertible preferred shares
Total perpetual convertible preferred shares
Noncontrolling interests subject to redemption; zero and 61,788 units as of December 31, 2023 and December 31, 2022, respectively
Shareholders’ equity:
Common shares, $0.001 par value; 800,000,000 shares authorized; 37,187,359 and 37,176,167 shares outstanding in the aggregate as of March 31, 2026 and December 31, 2025, respectively
Additional paid-in capital
Cumulative distributions
Accumulated earnings
Accumulated other comprehensive income (loss)
Total shareholders’ equity
Noncontrolling interests
Total equity
Total liabilities and equity
Units eligible towards redemption (in shares)
Common stock, shares outstanding (in shares)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support